# An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD

> **NCT07670702** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Transcend Therapeutics** · enrollment: 300 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** TSND-201

## Key facts

- **NCT ID:** NCT07670702
- **Lead sponsor:** Transcend Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-06-22
- **Primary completion:** 2028-12
- **Final completion:** 2029-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07670702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07670702, "An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07670702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*